These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 19192255)

  • 1. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection.
    Matsubara N; Kusano O; Sugamata Y; Itoh T; Mizuii M; Tanaka J; Yoshizawa H
    Transfusion; 2009 Mar; 49(3):585-95. PubMed ID: 19192255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
    Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
    Ogata N
    Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay].
    Ohne K; Kani S; Ohashi M; Shinkai N; Inoue T; Wakimoto Y; Tanaka Y
    Rinsho Byori; 2013 Sep; 61(9):787-94. PubMed ID: 24369590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.
    Yoshikawa A; Gotanda Y; Itabashi M; Minegishi K; Kanemitsu K; Nishioka K;
    Vox Sang; 2005 Feb; 88(2):77-86. PubMed ID: 15720604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients].
    Shinkai N; Tanaka Y; Matsuura K; Kani S; Naganuma H; Mizokami M
    Rinsho Byori; 2010 Nov; 58(11):1078-84. PubMed ID: 21229705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of hepatitis B surface antigen--prototype of a new fully automated HBsAg microparticle enzyme immunoassay (MEIA).
    Pfeifer K; Pelzer C; Coleman P; Pope M; Kapprell HP
    Clin Lab; 2003; 49(3-4):161-6. PubMed ID: 12705699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C.
    Komiya Y; Katayama K; Yugi H; Mizui M; Matsukura H; Tomoguri T; Miyakawa Y; Tabuchi A; Tanaka J; Yoshizawa H
    Transfusion; 2008 Feb; 48(2):286-94. PubMed ID: 18028278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples.
    Linauts S; Saldanha J; Strong DM
    Transfusion; 2008 Jul; 48(7):1376-82. PubMed ID: 18422847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-center evaluation of the hepatitis B surface antigen (HBsAg) assay and HbsAg confirmatory assay for the family of Access immunoassay systems.
    Lunel-Fabiani F; Duburcq X; Levayer T; Descamps F; Maniez-Montreuil M; Pivert A; Ducancelle A; Pouzet A; Marant L; Clèment A; Duhamel D; Leirens Y; Margotteau F; Falcou-Briatte R; Heinen C; Bouniort F; Taskar S; Artus A; Woodrum D; Flecheux O
    Clin Lab; 2010; 56(7-8):281-90. PubMed ID: 20857892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of HBsAg mutants.
    Osiowy C
    J Med Virol; 2006; 78 Suppl 1():S48-51. PubMed ID: 16622877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced antigenicity of naturally occurring hepatitis B surface antigen variants with substitutions at the amino acid residue 126.
    Qiu S; Zhang J; Tian Y; Yang Y; Huang H; Yang D; Lu M; Xu Y
    Intervirology; 2008; 51(6):400-6. PubMed ID: 19258718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
    Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
    J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
    Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.